AIM: To search candidate tumor suppressor genes (TSGs) on chromosome 4q through detecting high loss of heterozygosity (LOH) regions in sporadic colorectal carcinoma in Chinese patients. METHODS: Thirteen fluorescent labeled polymorphic microsatellite markers were analyzed in 83 cases of colorectal carcinoma and matched normal tissue DNA by polymerase chain reaction (PCR). PCR products were electrophoresed on an ABI 377 DNA sequencer. Genescan 3.7 and Genotype 3.7 software were used for LOH scanning and analysis. Comparison between LOH frequency and clinicopathological factors were performed by c2 test. RESULTS: Data were collected on all informative loci. The average LOH frequency on 4q was 28.56%. The D4S2915 locus showed highest LOH frequency (36.17%). Two obvious deletion regions were detected: one between D4S3000 and D4S2915 locus (4q12-21.1), another flanked by D4S407 and D4S2939 locus (4q25-31.1). None case showed complete deletion of 4q, most cases displayed interstitial deletion pattern solely. Furthermore, compared with clinicopathological features, a significant relationship was observed between LOH frequencies on D4S3018 locus. In tumors larger than 5 cm in diameter, LOH frequency was significantly higher than tumors that were less than 5 cm (56% vs 13.79%, P = 0.01). On D4S1534 locus, LOH was significantly associated with liver metastasis (80% vs 17.25%, P = 0.012). No relationship was detected on other locus compared with clinicopathological features. CONCLUSION: By high resolution deletion mapping, two high frequency regions of LOH (4q12-21.1 and 4q25-31.1) were detected, which may contribute to locate TSGs on chromosome 4q involved in carcinogenesis and progression of sporadic colorectal carcinoma.
AIM: To search candidate tumor suppressor genes (TSGs) on chromosome 4q through detecting high loss of heterozygosity (LOH) regions in sporadic colorectal carcinoma in Chinese patients. METHODS: Thirteen fluorescent labeled polymorphic microsatellite markers were analyzed in 83 cases of colorectal carcinoma and matched normal tissue DNA by polymerase chain reaction (PCR). PCR products were electrophoresed on an ABI 377 DNA sequencer. Genescan 3.7 and Genotype 3.7 software were used for LOH scanning and analysis. Comparison between LOH frequency and clinicopathological factors were performed by c2 test. RESULTS: Data were collected on all informative loci. The average LOH frequency on 4q was 28.56%. The D4S2915 locus showed highest LOH frequency (36.17%). Two obvious deletion regions were detected: one between D4S3000 and D4S2915 locus (4q12-21.1), another flanked by D4S407 and D4S2939 locus (4q25-31.1). None case showed complete deletion of 4q, most cases displayed interstitial deletion pattern solely. Furthermore, compared with clinicopathological features, a significant relationship was observed between LOH frequencies on D4S3018 locus. In tumors larger than 5 cm in diameter, LOH frequency was significantly higher than tumors that were less than 5 cm (56% vs 13.79%, P = 0.01). On D4S1534 locus, LOH was significantly associated with liver metastasis (80% vs 17.25%, P = 0.012). No relationship was detected on other locus compared with clinicopathological features. CONCLUSION: By high resolution deletion mapping, two high frequency regions of LOH (4q12-21.1 and 4q25-31.1) were detected, which may contribute to locate TSGs on chromosome 4q involved in carcinogenesis and progression of sporadic colorectal carcinoma.
Authors: H Okabe; I Ikai; K Matsuo; S Satoh; H Momoi; T Kamikawa; N Katsura; R Nishitai; O Takeyama; M Fukumoto; Y Yamaoka Journal: Hepatology Date: 2000-05 Impact factor: 17.425
Authors: Eun Song Cho; Joon Chang; Kyung Young Chung; Dong Hwan Shin; Young Sam Kim; Sung Kyu Kim; Se Kyu Kim Journal: Yonsei Med J Date: 2002-04 Impact factor: 2.759
Authors: R Arribas; R A Risques; I Gonzalez-Garcia; L Masramon; G Aiza; M Ribas; G Capellà; M A Peinado Journal: Lab Invest Date: 1999-02 Impact factor: 5.662
Authors: Takao Hinoi; Aytekin Akyol; Brian K Theisen; David O Ferguson; Joel K Greenson; Bart O Williams; Kathleen R Cho; Eric R Fearon Journal: Cancer Res Date: 2007-10-15 Impact factor: 12.701
Authors: Carolyn D Hurst; Heike Fiegler; Philippa Carr; Sarah Williams; Nigel P Carter; Margaret A Knowles Journal: Oncogene Date: 2004-03-18 Impact factor: 9.867
Authors: Seisho Takeuchi; Taku Seriu; Jacques J M van Dongen; Tomasz Szczepański; Kunihiro Tsukasaki; Naoko Takeuchi; Anthony C Fermin; Hiromi Seo; Claus R Bartram; H Phillip Koeffler Journal: Oncogene Date: 2003-10-09 Impact factor: 9.867
Authors: Carla O Rosario; Michael A Ko; Yosr Z Haffani; Rebecca A Gladdy; Jana Paderova; Aaron Pollett; Jeremy A Squire; James W Dennis; Carol J Swallow Journal: Proc Natl Acad Sci U S A Date: 2010-03-26 Impact factor: 11.205
Authors: Marianne Berg; Trude H Agesen; Espen Thiis-Evensen; Marianne A Merok; Manuel R Teixeira; Morten H Vatn; Arild Nesbakken; Rolf I Skotheim; Ragnhild A Lothe Journal: Mol Cancer Date: 2010-05-06 Impact factor: 27.401
Authors: María Arriba; Juan L García; Daniel Rueda; Jessica Pérez; Lorena Brandariz; Oana A Nutu; Laura Alonso; Yolanda Rodríguez; Miguel Urioste; Rogelio González-Sarmiento; José Perea Journal: Neoplasia Date: 2016-12-15 Impact factor: 5.715